Landscapes / Companies
Santen SAS not checked
FollowEvery new trial, moved date and filing, and a Monday email
Next date
None yet
Drugs
1
in active trials · 6 in all
Trials
1 active
6 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Santen Pharmaceutical |
Phase 3 | — | ||
| Also tested for | Acquired Blepharophimosis | ||||
| Open drug page | |||||
About
- No active trial
- DE-130A, DE-130A/DE-130A, Masked Ikervis, NOVA22007, Open-label Ikervis
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021